Pekin Hardy Strauss’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$20.8K Buy
2024
Q4
Sell
2024
Q3
$30.2K Sell
2024
Q2
$88.1K Sell
2024
Q1
$86.3K Sell
2023
Q4
$62K Sell
2023
Q3
$60.9K Sell
2023
Q2
$123K Sell
2023
Q1
$863K Sell
2022
Q4
$1.43M Sell
2022
Q3
$2.71M Buy
2022
Q2
$1.79M Buy
2022
Q1
$3.42M Buy
2021
Q4
$5.21M Buy
2021
Q3
$4.74M Sell
2021
Q2
$12.1M Buy
2021
Q1
$8.44M Buy
2020
Q4
$9.87M Sell
2020
Q3
$8.82M Buy
2020
Q2
$8.75M Buy
2020
Q1
$6.91M Buy
2019
Q4
$11.5M Buy